Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Marché Fermé - London S.E. 17:35:12 08/09/2026			Varia. 5j.	Varia. 1 janv.
1 796,50 ^GBX	-2,23%		-3,08%	-1,53%

08/09	GSK plc : RBC passe à neutre sur le dossier	ZD
08/09	GSK va lever 6,5 milliards de dollars sur le marché obligataire américain pour financer l'acquisition de Nuvalent	MT

Autres langues

08/09	GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition
08/09	GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition, Bloomberg Reports
08/09	FTSE 100 slips as Bailey flags inflation risks
08/09	European Stocks Close Mixed in Tuesday Trading; Oil Prices Surge As Middle East Fighting Worsens
08/09	GSK Commences Six-Part Dollar Bond Sale to Help Fund Nuvalent Acquisition
08/09	GSK Launches Six-Part Dollar Bond Sale to Support Nuvalent Acquisition Financing, Bloomberg Reports
08/09	Jefferies raises Autotrader and Rightmove
03/09	Global markets live: Apple, Microsoft, Tesla, Google, Uber…
03/09	Haleon Negotiates Better Shelf Placement at Walmart, Target
03/09	Wall Street im dreifachen Würgegriff
03/09	Afternoon Meeting: La triple amenaza que se cierne sobre Wall Street
03/09	Wall Street's Triple Squeeze
03/09	FTSE 100 edges higher; oil rises above USD97
03/09	WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit
03/09	Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830
03/09	Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%
03/09	Hutchmed Signs Cancer Treatment Licensing Agreement With GSK; Shares Rise Pre-Bell
03/09	LondonMetric investments; Jet2 eyes Main Market move
03/09	Morning Meeting: Comienzo sombrío de la temporada bursátil de otoño
03/09	Morning Meeting: Trüber Auftakt in den Börsenherbst
03/09	HUTCHMED Licenses Cancer Drug to GSK for Up to $1.30 Billion; Shares Up 12%
03/09	A gloomy start to the autumn trading season
03/09	HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug
03/09	Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
03/09	UK Stocks-Factors to watch on September 3